Spots Global Cancer Trial Database for Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
Official Title: A Prospective, Single-arm, Multicenter Clinical Study of Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent Nasopharyngeal Carcinoma
Study ID: NCT05350891
Conditions
Interventions
Study Description
Brief Summary: A Prospective, Single-arm, Multicenter Clinical Study of Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent Nasopharyngeal Carcinoma
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital of USTC(University of Science and Technology of China), Hefei, Anhui, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Fujian Provincial Hospital, Fuzhou, Fujian, China
Shenzhen Second People's Hospital, Shenzhen, Guangdong, China
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China
Shanghai Zhongshan Hospital,Fudan University, Shanghai, Shanghai, China
Contact Details
Name: Hongmeng Yu, MD,PHD
Affiliation: Eye&ENT Hospital,Fudan University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
